✦ LIBER ✦

Time-to-progression in breast cancer: A stratification model for clinical trials

✍ Scribed by Juan de la Haba-Rodríguez; Enrique Aranda; Antonio Llombart; Ana Lluch; Emilio Alba; Blanca Munárriz; Encarna Adrover; Ignacio Tusquets; Ana Balil; Agustí Barnadas; Lourdes Calvo; Miguel Martín

Book ID: 113506964
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 160 KB
Volume: 17
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2007.09.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progressive resistance training in breas

Progressive resistance training in breast cancer: a systematic review of clinical trials

✍ Bobby Cheema; Catherine A. Gaul; Kirstin Lane; Maria A. Fiatarone Singh 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 273 KB

Prolonged time to progression with fulve

Prolonged time to progression with fulvestrant for metastatic breast cancer

✍ Celso A. L. Mello; Ludmilla T. D. Chinen; Samantha Cabral Severino da Silva; Car 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 199 KB

Access to cancer care and clinical trial

Access to cancer care and clinical trials: A time for reappraisal

✍ Carolyn D. Rurtowicz; Michael L. Herman 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Inference in Spline-Based Models for Mul

Inference in Spline-Based Models for Multiple Time-to-Event Data, with Applications to a Breast Cancer Prevention Trial

✍ Kiros Berhane; Lisa A. Weissfeld 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Community readiness to promote Latinas’

Community readiness to promote Latinas’ participation in breast cancer prevention clinical trials

✍ Catalina R. Lawsin; Evelinn A. Borrayo; Ruth Edwards; Carolina Belloso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

Reasons for non-entry in randomized clin

Reasons for non-entry in randomized clinical trials for breast cancer: A single institutional study

✍ Dr. Cyrus A. Kotwall; Leo J. Mahoney; Robert E. Myers; Linda Decoste 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 440 KB

## Abstract Reasons for patient non‐entry in randomized clinical trials (RCTs) assessing oncologic treatment modalities are not well documented in the literature. We have prospectively recorded reasons for RCT non‐entry in breast cancer patients at St. Michael's Hospital, Toronto. From September 19